Overview

A Pharmacokinetics (PK) Study in Lice Infested Children 6 Months to 3 Years of Age

Status:
Completed
Trial end date:
2009-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the bioavailability of 0.5% ivermectin cream in a pediatric population aged 6 months to 3 years.
Phase:
Phase 1
Details
Lead Sponsor:
Topaz Pharmaceuticals Inc
Treatments:
Ivermectin